Omnicell was classified into the Zacks Medical Info Systems industry.
2 reports, 2 independent
Updated Jul 31
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Omnicell was classified into the Zacks Medical Info Systems industry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Omnicell
American healthcare technology company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- ZacksOmnicell (OMCL) Beats Q2 Earnings and Revenue Estimates Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to
- StockStory3 Healthcare Stocks We Approach with Caution From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory